|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 413/14 | (2006.01) |
| A61K 31/4439 | (2006.01) | ||
| A61K 31/501 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 3551627 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17816630.2 |
| Date of filing the European patent application | 2017-12-07 | |
| (97) | Date of publication of the European application | 2019-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-16 |
| (46) | Date of publication of the claims translation | 2022-04-25 |
| (86) | Number | PCT/EP2017/081768 |
| Date | 2017-12-07 |
| (87) | Number | WO 2018/104419 |
| Date | 2018-06-14 |
| (30) | Number | Date | Country code |
| 16202889 | 2016-12-08 | EP |
| (72) |
BUETTELMANN, Bernd , CH
CECERE, Giuseppe , CH
FASCHING, Bernhard , CH
GROEBKE ZBINDEN, Katrin , CH
HERNANDEZ, Maria-Clemencia , CH
KNUST, Henner , CH
KOBLET, Andreas , CH
PINARD, Emmanuel , CH
THOMAS, Andrew , CH
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Nauji izoksazolilo eterio dariniai kaip GABA A alfa5 teigiami alosteriniai moduliatoriai (PAM) |
| NEW ISOXAZOLYL ETHER DERIVATIVES AS GABA A ALPHA5 PAM |
| Payment date | Validity (years) | Amount | |
| 2025-11-19 | 9 | 208.00 EUR |
| 2026-12-07 |